CARDIO CON

Ahmedabad 2024
“Cardiodiagnostics”
announces

CARDIOCON
UPDATES - 2024
19TH & 20TH AUDITORIUM, SAL MEDICAL COLLEGE,
OCTOBER, 2024 SCIENCE CITY, AHMEDABAD

THEME - LEARNING ACROSS THE CARDIOVASCULAR CONTINUUM-

FROM PRIMARY PREVENTION TO HIGH RISK INTERVENTION IN CARDIOLOGY!

UNIQUE
“CASE BASED
DEBATE”
Format

Supported by:
DEAR FRIENDS AND COLLEAGUES,
GREETINGS FROM CARDIOCON!
We are delighted to announce that CARDIOCON 2024 will take place on the
19th and 20th of October 2024 in Ahmedabad, in a physical format.

CARDIOCON 2024 serves as a premier platform where clinicians,

researchers, and industry professionals come together to foster, bolster,
and advance treatment developments.

Young scientists and researchers are encouraged to submit their abstract

papers, providing them with a prestigious platform to showcase their
research in the field of Cardiology and related specialties.

CARDIOCON stands out with its unique format of case-based debates in car-
diology, gaining significant popularity over the last decade. The previous
event saw participation from over 5000 delegates from India and abroad.

CARDIOCON 2024 promises to offer an unparalleled experience, and we

eagerly anticipate your active participation in this esteemed conference.

Warm Regards,
Organizing Team
CARDIOCON 2024
 Committee

Dr. Kamal Sharma Dr. Mukesh Ladha Dr. Kalpesh Hansora

(Chairman, Scientific Committee)

Dr. Prashant Vazirani Dr. Kandarp Nimavat Dr. Neha Sharma

International Faculty

Dr. Mamas A. Mamas

(UK)
MD
Professor of Cardiology at
Keele University
and is a Practicing
Interventional Cardiologist

Dr. Purvi Parwani

(USA)
MD
Associate Professor of
Medicine (Cardiology) at Loma
Linda University

Dr. Romit Bhattacharya

(USA)
MD
Clinicn Investigator, Instruct
Cardiovascular Research Center,
Mass General Research Institute
Instructor in Medicine
Harvard Medical School

Dr. Shilpi Mohan

(USA)
MD
Interventional Cardiologist
Bishkek
Session 1 Session 2 Session 3
Preventive Cardiology Clinical, Therapeutics Interventional
and General Cardiology Cardiology
19th October 2024 (Saturday) 19th October 2024 (Saturday) 20th October 2024 (Sunday)
(Pre Lunch) (Post Lunch) (Pre Lunch)

10+
Debates

50+
Lectures

Daily Quiz based

Key on debates
with prizes

Facts 100+
Faculty

1 Scientific
Halls
 DIAGNOSTICS & PREVENTIVE
DAY-1 CARDIOLOGY SESSIONS
19TH October 2024 (Saturday)

BOUT 1 DIAGNOSTICS - "WOMEN-IN-CARDIOLOGY" - ARRHYTHMIA EVALUATION

A 42-year-old female with type II diabetes, dyslipidemia, and recent stress presents
with palpitations and nonspeci�ic ST-T changes in inferior leads. Her TMT was
inconclusive due to poor effort tolerance. Her LVEF on echocardiography is 65% with
12:00PM - no evident RWMA at rest and Grade I mitral valve prolapse. She had one episode of
syncope 2 years back, which was ascribed to "vasovagal syncope" by her treating
12:45PM physician. She has a family history of sudden cardiac death of her elder sister and
mother in their 50s. Her 48-hour Holter revealed 3% VPC burden without any
signi�icant pause. The best non-invasive strategy for her evaluation (rather than
invasive coronary angiography) would be -

Learning Objectives
1. Women in cardiology- Evaluation strategies
2. Role of Cardiac MR in CV evaluation
3. CT angiography and Gender variability

TALK 1: CVMRI would be helpful to evaluate arrhythmia, Dr. Purvi Parwani

RED CORNER ischemia, as well as structural abnormality if (USA)
10 (Mins) any.

TALK 2: CT angiography is a safe and reliable option to

Dr. Pooja Vyas
YELLOW CORNER rule out CAD as one of the commonest causes (Ahmedabad)
10 (Mins) of SCD in Indian women.

Referees (Chairpersons):
Dr. Dhaval Doshi Dr. Vishal Mehta Dr. Hasmukh Shah
(Ahmedabad) (Ahmedabad) (Ahmedabad)

Scorers (Moderators):
Dr. Kinnari Gupta Dr. Komal Shah Dr. Mital Prajapati
(Ahmedabad) (Gandhinagar) (Ahmedabad)

TAKE HOME MESSAGE AND PANEL DISCUSSION: 10 mins

BOUT 2 PREVENTIVE CARDIOLOGY - CARDIAC REHABILITATION

A 39-year-old hypertensive male presented with new-onset type II Diabetes. His lipids
12:45PM - showed TG of 270 mg%, HDL of 33 mg%, and LDL of 122 mg%. He is started on 20 mg
01:15PM of Rosuvastatin. Apart from optimal medical therapy (GDMT) for comorbidities, the
most important aspect of lifestyle modi�ication for him would be -

Learning Objectives
1. Cardiac Rehabilitation
2. Personalised & precision Medicine
3. Use of monitoring and Rehabilitative technology
4. Use of Technology (AI/ML) in Cardiology

TALK 3: Higher Genetic susceptibility in Asian Indians Dr. Romit Bhattacharya

BLUE CORNER warrants a more personalised dietary and (USA)
10 (Mins) Lifestyle modi�ication as compared to Caucasians

TALK 4: Technology driven lifestyle interventions,

Dr. Shilpi Mohan
RED CORNER dietary modi�ications and Psychological care (Hyderabad)
10 (Mins) are more important for Asian Subset

Referees (Chairpersons):
Dr. Prashant Advani Dr. Dhaval Doshi Dr. Krishna kumar Goyal
(Raipur)v (Ahmedabad) (Ahmedabad)

Scorers (Moderators):
Dr. Ketan Shah Dr. Komal Shah Dr. Kinnari Gupta Dr. Mital Prajapati
(Ahmedabad) (Gandhinagar) (Ahmedabad) (Ahmedabad)

TAKE HOME MESSAGE AND PANEL DISCUSSION: 10 mins

 DIAGNOSTICS & PREVENTIVE
DAY-1 CARDIOLOGY SESSIONS
19TH October 2024 (Saturday)

BOUT 3 CV RISK FACTOR- HYPERTENSION

A 55-year-old male presents with unstable angina, a 95% calci�ied, long LAD lesion with
01:45PM - TIMI II �low, resting ST-segment depression in anterior leads, LVEF of 55%, negative
02:15PM biomarkers, and a positive myocardial perfusion nuclear scan for ischemia at low
workload in the LAD territory. The best strategy for plaque modi�ication would be -

Learning Objectives
1. Resistant hypertension
2. Role of beta blockers in hypertension with Intrinsic Sympathetic over activity
3. Role of alpha blockers in CKD-BPH

TALK 5:
Adding BETA BLOCKER is preferable in view Dr.Kandarp Nimavat
BLUE CORNER
of the clinical pro�ile. (Ahmedabad)
10 (Mins)

TALK 6: Adding Alpha blocker would be the preferred Dr. Vishal Sharma
RED CORNER choice in patients as per the guidelines (Ahmedabad)
10 (Mins)

Referees (Chairpersons):
Dr. Jit Brahmbhatt Dr. Anil Kulshrestha Dr.Tarang Shah Dr.Vijay Maurya
(Ahmedabad) (Ahmedabad) (Ahmedabad) (TBD)

Scorers (Moderators):
Dr. Pragnesh Vachrajani Dr. Nurul Abbas Noorani Dr. Ravindra Thakkar Dr. Karan Patel
(Ahmedabad) (Ahmedabad) (Ahmedabad) (Ahmedabad)

TAKE HOME MESSAGE AND PANEL DISCUSSION: 10 mins

BOUT 4 CV RISK FACTOR- DYSLIPIDEMIA

A 37-year-old Male, diabetic with family history of CAD in younger brother presents
with 90% lesion in RCA with NSTEMI with LDL of 112 mg%, HDL of 32 mg% and TG of
12:45PM - 224 mg%. His Lp(a) is 60mg% and he is already on Rosuvastatin 20mg. His HBA1c is
01:15PM 6.4 mg%. He has history of intermittent drug default. The Best strategy
post-revascularization to manage his lipids apart from high dose statins, GDMT and
lifestyle modi�ication would be-

Learning Objectives
1. Newer LIPID goals (ESC and beyond)
2. PCSK-9 targeted therapies- Are Lipid vaccines here?
3. Triple drug therapy for Lipid lowering- Evidence and beyond

TALK 7:
PCSK9 targeted therapy (Inclisiran) is PROVEN Dr. J.P.S. Sawhney
BLUE CORNER
and a better strategy (Delhi )
10 (Mins)

TALK 8: BEMPEDOIC ACID + EZETEMIBE have

Dr. Prashant Vazirani
RED CORNER CLEAR-OUTCOMES and are much cheaper & (Ahmedabad)
10 (Mins) Effective to IMPROVE-IT

Referees (Chairpersons):
Dr. Atul Parikh Dr. Kamlesh Upadhyay Dr. Jitendra Patel Dr. Jayesh Trivedi
(Ahmedabad) (Ahmedabad) (Ahmedabad) (Ahmedabad)

Scorers (Moderators):
Dr. Dhiren Joshi Dr. Vijay Desai Dr. Nitin Parikh Dr. Chetan Bhalodia
(Ahmedabad) (Ahmedabad) (Ahmedabad) (Ahmedabad)

TAKE HOME MESSAGE AND PANEL DISCUSSION: 10 mins

 DIAGNOSTICS & PREVENTIVE
DAY-1 CARDIOLOGY SESSIONS
19TH October 2024 (Saturday)

BOUT 5 DIABETES, OBESITY AND CV risk Modi�ication - SGLT2 INHIBITORS/GLP-1a

A 50 years old Indian Male has weight of 96 kg. is on optimal cardiac medications for DM
type II with HBA1C of 8.9 mg% and BMI of 34.5 kg/m2. His LVEF is 55 % on
05:45PM - echocardiography with grade III diastolic dysfunction. He denies any breathlessness on
exertion but has discomfort on tying his shoelaces, which he ascribes to obesity (?
03:15PM Bendopnea). His e-GFR is 65 ml/kg/min2.He has history of Balanitis (? fungal) twice on
SGLT-2i in past. Best add on apart from lifestyle modi�ication, 1500 mg Metformin and
long acting insulin would be-

Learning Objectives
1. Risk calculators (SCORE-2 DM)
2. SGLT-2i in HFpEF
3. GLP-1a in Obesity and nephropathy
4. CV event reduction in DM management

TALK 9: SGLT-2 inhibitors can be re-challenged, as Dr. Sanjeev Phatak

BLUE CORNER overall bene�its outweigh the Fungal Genital (Ahmedabad)
10 (Mins) infection

TALK 10: GLP-1a are therapy of choice in OBESE diabetic Dr. Rucha Mehta
RED CORNER patients with CKD (Ahmedabad)
10 (Mins)

Referees (Chairpersons):
Dr. Prashant Advani Dr. Vivek Arya Dr. Zeeshan Mansuri Dr. Apurva Parekh
(Raipur) (Ahmedabad) (Ahmedabad) (Ahmedabad)

Scorers (Moderators):
Dr. G.R. Badlani Dr. Vinay Bhomiya Dr. Chintan Sagar Dr. Manish Aggrawal
(Ahmedabad) (Ahmedabad) (Bavla) (Ahmedabad)

TAKE HOME MESSAGE AND PANEL DISCUSSION: 10 mins

 DRUG THERAPY IN
DAY-1 CARDIOLOGY SESSIONS
19TH October 2024 (Saturday)

BOUT 6 NOAC- AF-VTE & PULMONARY EMBOLISM-CCS

A 55-year-old male presents with unstable angina, a 95% calci�ied, long LAD lesion with
03:15PM - TIMI II �low, resting ST-segment depression in anterior leads, LVEF of 55%, negative
04:00 PM biomarkers, and a positive myocardial perfusion nuclear scan for ischemia at low
workload in the LAD territory. The best strategy for plaque modi�ication would be -

Learning Objectives
1. May-Thurner syndrome
2. Risk factors of VTE
3. Scores and NOAC
4. NOAC and Thrombolysis in VTE & PE
5. NOAC in AF with CCS

TALK 11: Catheter Directed Thrombolysis with novel

Dr. Kalpesh Hansora
BLUE CORNER lytic agent is the most effective strategy both (Ahmedabad)
10 (Mins) for Large DVT and associated Pulmonary Embolism

TALK 12: RIVAROXABAN as NOAC is the most evidence Dr. Rahul Singhal
RED CORNER based therapy in such a scenario (Jaipur)
10 (Mins)

TALK 13: Dr. Anoop Gupta

YELLOW CORNER APIXABAN is the safest NOAC in this scenario (Ahmedabad)
10 (Mins)

Referees (Chairpersons):
Dr. Tarun Madan Dr. Kaushal Chaudhary Dr. Gaurang Patel Dr. Dhyanil Trivedi
(Ahmedabad) (Mehsana) (Mehsana) (Ahmedabad)

Scorers (Moderators):
Dr. Janak Khambholja Dr. Harshil Desai Dr. Kunal Jhaveri Dr. Jigar Gami
(Ahmedabad) (Ahmedabad) (Ahmedabad) (Ahmedabad)

TAKE HOME MESSAGE & PANEL DISCUSSION- All faculties- 15 min

BOUT 7 ANTIPLATELETS- HIGH RISK INTERVENTION- Choice of P2Y12 antagonist

A 65 years old diabetic, hypertensive male weighing 102 kg. with past history of
coronary angioplasty to Osteal RCA with DES implanted 6 months back is on Prasugrel
04:00PM - and Aspirin presents with Inferior wall STEMI. He had long lesion in RCA with
04:45PM restenosis and underwent PTCA with 3 DES totalling 80 mm in length. He also has de
novo type B lesions in both LAD and LCX requiring revascularisation. The ideal
antiplatelet in this scenario apart from aspirin would be -

Learning Objectives
1. DAPT in Recurrent events
2. Bridging therapy
3. DAPT Scores
4. High risk interventions

TALK 14:
Ticagrelor is an all season antiplatelet with Dr. Tarun Dave
BLUE CORNER
higher ef�icacy (Ahmedabad)
10 (Mins)

TALK 15: Clopidogrel is the preferred Antiplatelet given Dr. Vinod Vijan
RED CORNER for his risk pro�ile for long term! (Nashik)
10 (Mins)

TALK 16: Cangrelor is the safest choice amongst the three Dr. Vipul Kapoor
Yellow CORNER options in view of LAD/LCX revascularisation (Ahmedabad)
10 (Mins) later on.

Referees (Chairpersons):
Dr. Nikunj Patel Dr. Devratsinh Parmar Dr. Nirmal Shah Dr. Saurabh
(Mehsana) (Ahmedabad) (Ahmedabad) (Modasa)

Scorers (Moderators):
Dr. Gyanendra Singh Dr. Mustafa Rangwala Dr. Umesh Gedia Dr. Kashyap Buch
(Ahmedabad) (Ahmedabad) (Surendranagar) (Bhuj)

TAKE HOME MESSAGE AND PANEL DISCUSSION- All Faculties- 15 Min

 DRUG THERAPY IN
DAY-1 CARDIOLOGY SESSIONS
19TH October 2024 (Saturday)

BOUT 8 ACUTE HEART FAILURE HOSPITALISATION

A 65-years-old female with normal QRS duration of 90ms. with normal coronary
angiography has NYHA Class 3 dyspnea with severe LV DYSFUNCTION with LVEF 20%
with BP of 100/62 mmHg. Her creatinine is 1.89 mg.% with eGFR of 32 ml/min/m2. She
04:45PM - was on diuretics, digitalis, Telmisartan and MRA which she stopped for last 2 weeks due
05:30 PM to nausea and vomiting. She was hospitalised for heart failure 2 months back. Her
haemoglobin is 10 gm% with low serum iron and high TIBC. What would be the best
sequence for her after stabilisation for acute decompensation -

Learning Objectives
1. 4 pillars of heart failure
2. FCM in Iron de�iciency
3. Recurrent Hospitalisation prevention
4. How to initiate the therapy?

TALK 17:
ARNI with beta-blockers ahead of SGLT2-i Dr. Mahesh Fulwani
RED CORNER
would be the game changer despite altered eGFR (Nagpur)
10 (Mins)

TALK 18: Adding Vericiguat with SGLT2-I and beta-blocker Dr. Bhavesh Roy
BLUE CORNER instead of ARNI would be the safest strategy (Jaipur)
10 (Mins) as the starting choice

TALK 19: IV FCM has safest drug pro�ile and should be Dr. Hemang Baxi
YELLOW CORNER chosen ahead of others - (TBD)
10 (Mins)

Referees (Chairpersons):
Dr. Jay Shah Dr. Aalap Patel Dr. Mahadev Desai Dr. Joyal Shah
(Ahmedabad) (Mehsana) (Ahmedabad) (Ahmedabad)

Scorers (Moderators):
Dr. Rajendra Gurnani Dr. Anant Yadav Dr. Jayesh Pawra Dr. Bhargav Solanki
(Ahmedabad) (Ahmedabad) (Ahmedabad) (Ahmedabad)

TAKE HOME MESSAGE AND PANEL DISCUSSION – All Panellist - 15 Min

BOUT 9 DIABETIC HEART FAILURE- MRAs –The Underutilised intervention!

A 55-years-old male, diabetic for last 10 years and Post-PTCA status 2 years back for
05:30PM - double vessel disease in NYHA Class 3 with Moderate LV DYSFUNCTION with LVEF 40
% with BP of 112/62 mmHg. Her creatinine is 1.6 mg.% with e-GFR of 45 ml/min/m2
06:00PM and UACR of 330 mg/gm. She is on Torsemide, Telmisartan and Dapagli�lozin. Her
serum potassium is 4.4mg%. What would be the choice of MRA for her management-?

Learning Objectives
1. MRA in heart failure
2. Diabetic kidney disease(DKD) subset of heart failure
3. Differences between various MRA

TALK 20:
Finerenone is the proven therapy for Dr. Sunil Thanvi
RED CORNER
DKD patients (Ahmedabad)
10 (Mins)

TALK 21: EPLERENONE is more studied in ACS as well Dr. Jagdish Hiremath
BLUE CORNER as heart failure patients (Pune)
10 (Mins)

Referees (Chairpersons):
Dr. Riyaz Charaniya Dr. Vyom Mori Dr. Chirag Patel Dr. Kunal Parwani
(Mehsana) (Junagadh) (Ahmedabad) (Ahmedabad)

Scorers (Moderators):
Dr. Nehal Sadhu Dr. Dinkar Goswami Dr. Dharmesh Prajapati Dr. Devendrasinh zala
(Ahmedabad) (Ahmedabad) (Surendranagar) (Sanand)

TAKE HOME MESSAGE AND PANEL DISCUSSION – All Panellist -10 min
 DRUG THERAPY IN
DAY-1 CARDIOLOGY SESSIONS
19TH October 2024 (Saturday)

BOUT 10 High risk CAD- Long term strategy

A 70-year-old male diabetic, hypertensive and strong family history with past history of
04:45PM - TIA 5 years back and post PTCA status with 2 stents, 1 year back for AWMI comes for
05:30 PM follow up. Apart from medical optimization and lifestyle modi�ication best strategy for
risk reduction would be –

Learning Objectives
1. High CV risk scores- Residual SYNTAX and beyond
2. Trials- TWILIGHT, PEGASIS-TIMI, COMPASS & VOYAGER
3. Rationalising Therapy based on risk pro�iles

TALK 22:
Dr. Abhisheka Tripathi
RED CORNER RIVAROXABAN 2.5 mg BD with aspirin (Ahmedabad)
10 (Mins)

TALK 23: Dr. Gajendra Dubey

BLUE CORNER TICAGRELOR 60 mg BD with aspirin (Ahmedabad)
10 (Mins)

Referees (Chairpersons):
Dr. Sharad Jain Dr. Sanjiv Bhatia Dr. Rajanya Patel Dr. Sandarbh Patel
(Ahmedabad) (Mehsana) (Himmatnagar) (Ahmedabad)

Scorers (Moderators):
Dr. Bhagirath Solanki Dr. Shashi Mundra Dr. Sunil Tyagi Dr. Prathmesh Chaudhary
(Ahmedabad) (Gandhinagar) (Ahmedabad) (Ahmedabad)

TAKE HOME MESSAGE AND PANEL DISCUSSION: 10 Min

BOUT 11 DIABETIC HEART FAILURE- MRAs –The Underutilised intervention!

A 76-year-old male with history of typical angina with history of CABG 4 years back for
06:30PM - triple vessel disease, now has occluded SVG to RCA graft but patent SVG to LCX and
LIMA to LAD. Stress radio- nuclear imaging had revealed mild reversible ischemic
07:15PM territory of LCX (SDS=3). His LVEF is 40% and has class II angina along with class II
dyspnea on glycerine trinitrate 6.4 mg twice daily apart from DAPT and high dose
statins. He is already on Metoprolol 100 mg per day, ARNI and SGLT2-i. His resting
heart rate is 78 bpm and BP of 106/70 mmHg. He has occasional VPC on ECG. His
coronary angiogram revealed slow �low in native RCA with borderline troponins but
normal CPKMB. The preferred modality of next line of anti-anginal would be –

Learning Objectives
1. Drug treatment for stable CAD
2. Heart failure and Ivabradine in CAD
3. Antiarrhythmic action of Ranolazine
4. Nikorandil and INOCA and MINOCA

TALK 24:
Ivabradine is the preferred drug in view of Dr. Shomu Bohora
RED CORNER
elevated resting heart rate and LV dysfunction (Vadodara)
10 (Mins)

TALK 25: Ranolazine is the preferred antianginal in view Dr. Jayesh Prajapati
BLUE CORNER of additional anti-arrhythmic bene�its. (Ahmedabad)
10 (Mins)

TALK 26: Dr. Ajay Mahajan

YELLOW CORNER Nikorandil has most evidence in MINOCA/INOCA (Mumbai)
10 (Mins)

Referees (Chairpersons):
Dr. Jayal Shah Dr. Uttam Chandarana Dr. Abhimanyu singh Dr. Kamlesh Fatania
(Ahmedabad) (Vadodara) (Adipur) (Ahmedabad)

Scorers (Moderators):
Dr. Surendra Gupta Dr. Shabbir Gadi Dr. Rajeev Sabnani Dr. Vimal Prajapati
(Palanpur) (Ahmedabad) (Ahmedabad) (Ahmedabad)

TAKE HOME MESSAGE AND PANEL DISCUSSION- All Panellists – 15 min

 INTERVENTIONAL
DAY-2 CARDIOLOGY SESSIONS
20TH October 2024 (Sunday)

BOUT 12 VALVULAR HEART DISEASE

A 77-year-old Male has exertional angina class III and 1 episode of Pre-syncope. She
also has obstructive pattern on PFT with COPD which is currently well controlled on
oral medication and occasional inhalers. He has normal coronaries with LMCA “take
09:30AM - off” 6 mm from the aortic valve with SEVERE Bicuspid and calci�ied Aortic Stenosis
10:00AM with gradient of 88/ 42 mmHg on TTE with Normal LV systolic function with AV
area=0.7 cm.sq. His STS score is 6 (intermediate) with suitable lower limb and valve
CT. She also has severe MR with Carpentier Type II with mild PAH with
LVDD/Ds=52/32 mm. The best strategy for him would be-

Learning Objectives
1. TAVR vs SAVR
2. TMVR vs MV repair
3. Identi�ication of appropriate candidates
4. Post-procedure management

TALK 27:
Transcatheter aortic valve replacement with Dr. Abhishek Rajpopat
RED CORNER
Transcather mitraclip (TAVR+TMVR) (Ahmedabad)
10 (Mins)

TALK 28: Minimal invasive Surgical Aortic valve replacement Dr. Priyank Bhatt
BLUE CORNER (SAVR) with MV repair will remain gold standard. (Ahmedabad)
10 (Mins)

Referees (Chairpersons):
Dr. Manek Chopra Dr. Tushar Shah Dr. Aman Tejas Patel Dr. Roopesh Singhal
(Ahmedabad) (Ahmedabad) (Ahmedabad) (Ahmedabad)

Scorers (Moderators):
Dr. Jignesh Vanani Dr. Nilesh Patel Dr. Jayesh Meniya Dr. Abhrajyoti Biswas
(Botad) (Palanpur) (Surendranagar) (Ahmedabad)

TAKE HOME MESSAGE AND PANEL DISCUSSION: All Panellists- 10 Min

INAUGURATION & ICON OF CARDIOCON CEREMONY – 10 AM TO 10:30AM

BOUT 13 ISR MANAGEMENT-DRUG ELUTING BALLOON /STENTING

10:30AM - A 68 years old Male, post PTCA LMCA to LAD status 2 years back, presented with
NSTEMI with patent stent to LCX with 80% Osteal Lesion with a large high OM/RI
11:15AM branch arising from the across the previous stent size 4.5x 38 mm.

Learning Objectives
1. Management of osteal lesions
2. DEB as the alternative management for ISR
3. Use of Imaging in ISR

TALK 29: Paclitaxel drug coated balloon assisted by

Dr.Chirag Sheth
BLUE CORNER imaging is preferred strategy for LCX osteal (Vadodara)
10 (Mins) revascularisation

TALK 30: Being atherosclerotic in nature, DE novo Dr. Hasit Joshi

RED CORNER stenting of LCX is the best solution (Ahmedabad)
10 (Mins)

TALK 31: Sirolimus Drug eluting balloon with

Dr.Mahpaekar Mashhadi
RED CORNER Nano-technology is the best strategy (Ahmedabad)
10 (Mins) for branch vessel revascularisation

Referees (Chairpersons):
Dr. Sibasis Sahoo Dr. Kapil Virpariya Dr. Saurin Shah Dr. Dharmin Bhalodia
(Ahmedabad) (Rajkot) (Ahmedabad) ( Junagadh)

Scorers (Moderators):
Dr. Dinesh Joshi Dr. Devender Sharma Dr. Spandan Patel Dr. Pradeep Bansal
(Ahmedabad) (Patan) (Ahmedabad) (Ahmedabad)

TAKE HOME MESSAGE AND PANEL DISCUSSION: All Panellists- 15 Min

 INTERVENTIONAL
DAY-2 CARDIOLOGY SESSIONS
20TH October 2024 (Sunday)

BOUT 14 STENT SELECTION

11:15AM - A 50-year-old Doctor with Diabetes, unstable angina is planned to undergo PTCA to
tortuous angulated long 90% mid LCX lesion with Large OM arising across it. The stent
11:45AM parameter that helps in choosing this stenting would be –

Learning Objectives
1. Knowing architecture of stents to choose the stent
2. Drug elution patterns vs polymers
3. Trackability vs radial strength of stents

TALK 32: Stent design parameters’ (viz. Strut thickness,

Dr. V.C.Chauhan
RED CORNER trackability, radial strength, side branch access (Vadodara)
10 (Mins) etc.) are more important parameters

TALK 33: Drug platform (dose, elution pro�ile) and polymer

Dr. Mukesh Laddha
BLUE CORNER (bio degradable) are more important determinants (Ahmedabad)
10 (Mins) with availability of new delivery systems / catheters.

Referees (Chairpersons):
Dr. Sanjay Shah Dr. Anand Shukla Dr. Kamlesh Thakkar Dr. Kiran Prajapati
(Ahmedabad) (Ahmedabad) (Mehsana) (Ahmedabad)

Scorers (Moderators):
Dr. Ravi Singhvi Dr. Ronak Shah Dr. Jignesh D Patel Dr. Nikunj Kotecha
(Ahmedabad) (Himmatnagar) (Godhara) (Rajkot)

TAKE HOME MESSAGE AND PANEL DISCUSSION: 10 Min

BOUT 15 PLAQUE MODIFICATION

A 55 years old male has unstable angina with 95 % calci�ied, long LAD lesion with TIMI
II �low with resting ST depression and deep T inversion on ECG changes in anterior
11:45AM -
leads with LVEF of 55% with negative biomarkers and positive Myocardial perfusion
12:30PM nuclear scan for ischemia at low workload in the LAD territory. Best Strategy for the
plaque modi�ication would be -

Learning Objectives
1. Knowing architecture of stents to choose the stent
2. Drug elution patterns vs polymers
3. Trackability vs radial strength of stents

TALK 34:
Rotational athrectomy is preferred strategy Dr. Prakashveer Parikh
BLUE CORNER
- OLD IS GOLD! (Ahmedabad)
10 (Mins)

TALK 35: Prof. Mamas A Mamas

RED CORNER IVL is a game-changer with minimal risks! (U.K.)
10 (Mins)

TALK 36: ORBITAL ATHRECTORMY is the best Dr. Tejas V Patel

RED CORNER modality for these kind of lesions! (Ahmedabad)
10 (Mins)

Referees (Chairpersons):
Dr. Jayesh Rawal Dr. Bhupesh Shah Dr. Pratik Raval Dr. Tejas Shah
(Ahmedabad) (Ahmedabad) (Ahmedabad) (Ahmedabad)

Scorers (Moderators):
Dr. Jevin Jhameria Dr. Varun Sibal Dr. Hemal Thakkar Dr. Pankaj Singh
(Ankleshwar) (Bhavnagar) (Palanpur) (Ahmedabad)

TAKE HOME MESSAGE AND PANEL DISCUSSION: 10 Min

 INTERVENTIONAL
DAY-2 CARDIOLOGY SESSIONS
20TH October 2024 (Sunday)

BOUT 16 STENT SELECTION

A 55 years old Male with grade II dyspnea shows LAHB with RBBB with QRSd of 130ms
12:30PM - with 240 ms PR interval. His 24 hour holter monitoring yielded pauses>3 seconds.
There is history of “cardiac syncope” thrice over last 1 years. He has history of old
01:00PM anteroseptal MI with Recanalised coronaries in a recent coronary angiography. His
CVMRI shows small apical scar with LVEF of 42%. Apart from medical optimisation-

Learning Objectives
1. Evaluation of Syncope
2. Concept of His bundle/Left bundle pacing
3. CRT-D in Ischemic Heart failure and syncope

TALK 37:
CRT-P will be more suitable as preferred Dr. Sameer Rane
BLUE CORNER
device therapy (Ahmedabad)
10 (Mins)

TALK 38: Left Bundle Pacing (DDDR) of Left Bundle Dr. Niraj Yadav
RED CORNER Pacing alone shall suf�ice as of now (Ahmedabad)
10 (Mins)

Referees (Chairpersons):
Dr.Anoop Gupta Dr.Chirayu Vyas Dr Raghav Bansal Dr Priyanka Aggrawal
(Ahmedabad) (Ahmedabad) (Mehsana) (Ahmedabad)

Scorers (Moderators):
Dr. Shubham Sharma Dr Hasmukh Shah Dr. Gunjun Shah Dr. Vicky Garhwal
(Ahmedabad) (Karamsad) (Ahmedabad) (Ahmedabad)

TAKE HOME MESSAGE AND PANEL DISCUSSION: All Panellists- 10 min

BOUT 17 CABG vs PCI in LV aneurysm

A 70 years old Male without DM or HTN with history of AWMI 3 years back presents
with NSTEMI with 99% Type A proximal LAD lesion and 90% type A lesion in Major
01:00PM - OM.His echocardiography shows Severe LV dysfunction with LV apical aneurysm
without any clot and no signi�icant MR without annular dilatation. He is further
01:30PM evaluated for LAD territory for viability on SPECT and cardiac MR which shows
non-viable distal LAD territory with viable proximal LAD and other vessel territory.
Best Strategy would be -

Learning Objectives
1. Viability/Ischemia assessment prior to revascularisation
2. Comparison of PCI vs CABG/SVR
3. Surgical volume restoration-STICTH Trial

TALK 39:
CABG with SVR is a better in restoring LV Dr. Anil Jain
BLUE CORNER
geometry along with revascularisation (Ahmedabad)
10 (Mins)

TALK 40: PTCA to LAD and OM is the best strategy of Dr. Kamal Sharma
RED CORNER revascularisation for him as per viabili (Ahmedabad)
10 (Mins)

Referees (Chairpersons):
Dr. Mihir Tanna Dr. Atul Mashlekar Dr. Alpesh Patel Dr. Kartik Natrajan
(Rajkot) (Ahmedabad) (Ahmedabad) (Ahmedabad)

Scorers (Moderators):
Dr.Ketan Joshi Dr. Anci Shah Dr. Harshad Patel Dr. Rakesh Sharma
(Visnagar) (Ahmedabad) (Ahmedabad) (Ahmedabad)

TAKE HOME MESSAGE AND PANEL DISCUSSION: All Panellist- 15 MIN

LUNCH-1:30 onwards
 VENUE:
AUDITORIUM, SAL MEDICAL COLLEGE,
SCIENCE CITY, AHMEDABAD

Limited registration on first come basis

E-posters with certification